Niva Bupa Health Insurance Company Limited has informed the Exchange regarding receipt of IRDAI approval on September 24, 2025 for the appointment of Mr. Milind Gajanan Barve (DIN: 00087839) as the Chairman of the Board of Directors with effect from August 28, 2025.
NIVABUPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts more than Nifty Smallcap 250 and 0.3 pts more than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Niva Bupa Health Insurance has received approval from the insurance regulator IRDAI for the appointment of Mr. Milind Gajanan Barve (DIN: 00087839) as the Chairman of its Board of Directors. The appointment is effective from August 28, 2025, with the regulatory approval granted on September 24, 2025. This is a routine disclosure under SEBI Listing Regulations, confirming regulatory clearance for the board leadership position. Mr. Barve is a seasoned financial services professional known for his long tenure at HDFC Asset Management.
This formalises and validates the company's board leadership, which is generally seen as a positive governance signal for shareholders. With regulatory approval secured, investors can expect greater continuity and strategic direction at the board level.